31
TITLE: Evaluation of opicapone's cardiac safety in patients with Parkinson's disease: analysis of the centralized phase III ECG dataset  Full Text
AUTHORS: Vaz da Silva, M; Pinto, R ; Lopes, N; Ferreira, J; Lees, A; Gama, H; Santos, A; Oliveira, C; Nunes, T; Rocha, JF; Soares da Silva, P;
PUBLISHED: 2015, SOURCE: 1st Congress of the European-Academy-of-Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
32
TITLE: Evaluation of the safety and tolerability of opicapone in the treatment of Parkinson's disease and motor fluctuations: analysis of pooled phase III studies  Full Text
AUTHORS: Gama, H; Ferreira, J; Lees, A; Lopes, N; Santos, A; Costa, R; Oliveira, C; Pinto, R ; Nunes, T; Rocha, JF; Soares da Silva, P;
PUBLISHED: 2015, SOURCE: 1st Congress of the European-Academy-of-Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
33
TITLE: Pooled efficacy analysis of opicapone as adjunctive therapy to levodopa in patients with Parkinson's disease and motor fluctuations  Full Text
AUTHORS: Ferreira, J; Lees, A; Santos, A; Lopes, N; Costa, R; Oliveira, C; Pinto, R ; Nunes, T; Rocha, JF; Soares da silva, P;
PUBLISHED: 2015, SOURCE: 1st Congress of the European-Academy-of-Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
34
TITLE: QT/QTc evaluation of opicapone in healthy adults.  Full Text
AUTHORS: Vaz da Silva, M; Pinto, R ; Lopes, N; Santos, A; Nunes, T; Rocha, JF; Soares da Silva, P;
PUBLISHED: 2015, SOURCE: 1st Congress of the European-Academy-of-Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
35
TITLE: Safety of opicapone in patients with Parkinson's disease and motor fluctuations: 1-year follow-up  Full Text
AUTHORS: Lees, A; Ferreira, J; Costa, R; Oliveira, C; Pinto, R ; Lopes, N; Nunes, T; Rocha, JF; Soares da silva, P;
PUBLISHED: 2015, SOURCE: 1st Congress of the European-Academy-of-Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
36
TITLE: Effect of moderate liver impairment on the pharmacokinetics of opicapone  Full Text
AUTHORS: Rocha, JF; Santos, A; Falcao, A ; Lopes, N; Nunes, T; Pinto, R ; Soares da Silva, P ;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 70, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 25
IN MY: ORCID
37
TITLE: Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations  Full Text
AUTHORS: Jose Francisco Rocha; Amilcar Falcao; Ana Santos; Roberto Pinto ; Nelson Lopes; Teresa Nunes; Lyndon C Wright; Manuel Vaz da Silva ; Patricio Soares da Silva ;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 70, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 54
IN MY: ORCID
38
TITLE: Opicapone effect on levodopa pharmacokinetics in comparison with placebo and entacapone when administered with immediate release 100/25 mg levodopa/carbidopa in healthy subjects  Full Text
AUTHORS: Rocha, JF; Falcao, A; Lopes, N; Pinto, R ; Santos, A; Nunes, T; Soares da Silva, P;
PUBLISHED: 2014, SOURCE: Joint Congress of European Neurology in JOURNAL OF NEUROLOGY, VOLUME: 261
INDEXED IN: WOS
IN MY: ORCID
39
TITLE: Opicapone effect on levodopa pharmacokinetics in comparison with placebo and entacapone when administered with immediate release 100/25mg levodopa/carbidopa in healthy subjects  Full Text
AUTHORS: Rocha, JF; Falcao, A; Lopes, N; Pinto, R ; Santos, A; Nunes, T; Soares da Silva, P;
PUBLISHED: 2014, SOURCE: Joint Congress of European Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 21
INDEXED IN: WOS
IN MY: ORCID
40
TITLE: Opicapone long-term efficacy and safety in Parkinson's disease BIPARK-II study: a one-year open-label follow-up  Full Text
AUTHORS: Costa, R; Oliveira, C; Pinto, R ; Lopes, N; Nunes, T; Rocha, JF; Soares da Silva, P;
PUBLISHED: 2014, SOURCE: Joint Congress of European Neurology in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 21
INDEXED IN: WOS
IN MY: ORCID
Página 4 de 5. Total de resultados: 50.